These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

94 related articles for article (PubMed ID: 24843596)

  • 1. Present status of insulin therapy for type 2 diabetes treated by general practitioners and diabetes specialists in Japan: Third report of a cross-sectional survey of 15,652 patients.
    Arai K; Takai M; Hirao K; Matsuba I; Matoba K; Takeda H; Kanamori A; Yamauchi M; Mori H; Terauchi Y
    J Diabetes Investig; 2012 Aug; 3(4):396-401. PubMed ID: 24843596
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The status of glycemic control by general practitioners and specialists for diabetes in Japan: a cross-sectional survey of 15,652 patients with diabetes mellitus.
    Arai K; Hirao K; Matsuba I; Takai M; Matoba K; Takeda H; Kanamori A; Yamauchi M; Mori H; Terauchi Y
    Diabetes Res Clin Pract; 2009 Mar; 83(3):397-401. PubMed ID: 19124170
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Real-world Observational Study on Patient Outcomes in Diabetes (RESPOND): study design and baseline characteristics of patients with type 2 diabetes newly initiating oral antidiabetic drug monotherapy in Japan.
    Yabe D; Higashiyama H; Kadowaki T; Origasa H; Shimomura I; Watada H; Tobe K; Iglay K; Tokita S; Seino Y
    BMJ Open Diabetes Res Care; 2020 Nov; 8(2):. PubMed ID: 33188008
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Cross sectional study on proportion of sulfonylureas among various oral antidiabetic drugs using for Japanese patients with type 2 diabetes, analyzed from NSAID Study-2.
    Arai K; Nishikawa T; Shirabe SI; Matsuzawa Y; Ohtsu S; Yuasa S; Hirao K; Mori H
    Diabetol Int; 2022 Jan; 13(1):169-176. PubMed ID: 35059253
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Evaluation of insulin regimens as an effective option for glycemic control in patients with type 2 diabetes: A propensity score-matched cohort study across Japan (JDDM31).
    Kanatsuka A; Sato Y; Kawai K; Hirao K; Kobayashi M; Kashiwagi A;
    J Diabetes Investig; 2014 Sep; 5(5):539-47. PubMed ID: 25411622
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Nationwide Survey on Actual Interventions for Type 2 Diabetes by Japanese Practitioners (NSAID Study-1): Glycemic, Weight, and Blood Pressure Management.
    Arai K; Nishikawa T; Yuasa S; Shirabe SI; Matsuzawa Y; Ohtsu S; Hirao K; Mori H
    Diabetes Ther; 2020 Jul; 11(7):1497-1511. PubMed ID: 32440836
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Efficacy and safety of patient-directed titration of once-daily pre-dinner premixed biphasic insulin aspart 70/30 injection in Japanese type 2 diabetic patients with oral antidiabetic drug failure: STEP-AKITA study.
    Narita T; Goto T; Suganuma Y; Hosoba M; Morii T; Sato T; Fujita H; Miura T; Shimotomai T; Yamada Y; Kakei M
    J Diabetes Investig; 2011 Jan; 2(1):63-70. PubMed ID: 24843463
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Comparison of the Effect of Glycemic Control in Type 2 Diabetes Outpatients Treated With Premixed and Basal Insulin Monotherapy in China.
    Liu G; Dou J; Pan Y; Yan Y; Zhu H; Lu J; Gaisano H; Ji L; He Y
    Front Endocrinol (Lausanne); 2018; 9():639. PubMed ID: 30420835
    [No Abstract]   [Full Text] [Related]  

  • 9. Characteristics, Treatment Patterns, and Economic Outcomes of Patients Initiating Injectable Medications for Management of Type 2 Diabetes Mellitus in Japan: Results from a Retrospective Claims Database Analysis.
    Suzuki S; Desai U; Strizek A; Ivanova J; Garcia-Horton V; Cai Z; Schmerold L; Liu X; Perez-Nieves M
    Diabetes Ther; 2018 Jun; 9(3):1125-1141. PubMed ID: 29663262
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Which Patients Will Benefit from a Switch in Therapy from Premixed Insulin to Insulin Glargine plus Oral Antidiabetic Drugs? Further Analysis of the Lantus Registry Study.
    Bu S; Zhang X; Zhu H; Shuai Y; Xing X; Yang W;
    Diabetes Ther; 2017 Aug; 8(4):887-898. PubMed ID: 28623551
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Changes in oral antidiabetic prescriptions and improved glycemic control during the years 2002-2011 in Japan (JDDM32).
    Oishi M; Yamazaki K; Okuguchi F; Sugimoto H; Kanatsuka A; Kashiwagi A;
    J Diabetes Investig; 2014 Sep; 5(5):581-7. PubMed ID: 25411627
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Factors Influencing the Prescribing Preferences of Physicians for Drug-Naive Patients with Type 2 Diabetes Mellitus in the Real-World Setting in Japan: Insight from a Web Survey.
    Murayama H; Imai K; Odawara M
    Diabetes Ther; 2018 Jun; 9(3):1185-1199. PubMed ID: 29696567
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Repaglinide : a pharmacoeconomic review of its use in type 2 diabetes mellitus.
    Plosker GL; Figgitt DP
    Pharmacoeconomics; 2004; 22(6):389-411. PubMed ID: 15099124
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A Real-World Observational Study Evaluating the Probability of Glycemic Control with Basal Insulin or Glucagon-Like Peptide-1 Receptor Agonist in Japanese Patients with Type 2 Diabetes.
    Baxter M; Morimoto Y; Tamiwa M; Hattori M; Peng XV; Lubwama R; Maegawa H
    Diabetes Ther; 2020 Jul; 11(7):1481-1496. PubMed ID: 32445125
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Attitudes towards insulin initiation in type 2 diabetes patients among healthcare providers: A survey research.
    Escalada J; Orozco-Beltran D; Morillas C; Alvarez-Guisasola F; Gomez-Peralta F; Mata-Cases M; Palomares R; Iglesias R; Carratalá-Munuera C
    Diabetes Res Clin Pract; 2016 Dec; 122():46-53. PubMed ID: 27810685
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Efficacy and safety of sitagliptin monotherapy and combination therapy in Japanese type 2 diabetes patients.
    Kubota A; Maeda H; Kanamori A; Matoba K; Jin Y; Minagawa F; Obana M; Iemitsu K; Ito S; Amamiya H; Kaneshiro M; Takai M; Kaneshige H; Hoshino K; Ishikawa M; Minami N; Takuma T; Sasai N; Aoyagi S; Kawata T; Mokubo A; Takeda H; Honda S; Machimura H; Motomiya T; Waseda M; Naka Y; Tanaka Y; Terauchi Y; Matsuba I
    J Diabetes Investig; 2012 Dec; 3(6):503-9. PubMed ID: 24843615
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Patient and General Practitioner characteristics influencing the management of non-insulin-treated diabetes mellitus: A cross-sectional study in Italy.
    Ferroni E; Casotto V; Pigato M; Scroccaro G; Corti MC; Fedeli U; Saugo M
    Diabetes Res Clin Pract; 2016 Jun; 116():192-201. PubMed ID: 27321335
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [POET2 registry: Comparison of annual direct medical costs of treating type 2 diabetes after addition of insulin NPH or insulin glargine to oral antidiabetic therapy in the Czech Republic].
    Kvapil M; Žďarská DJ; Suchopár J; Prokeš M; Brož J
    Vnitr Lek; 2015 Jan; 61(1):24-32. PubMed ID: 25693613
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Association of diabetic ketoacidosis, severe hypoglycemia and glycemic control among children and young adults with type 1 diabetes mellitus treated with premixed versus basal-bolus insulin therapy.
    Chou WY; Li YR; Chan WK; Chen ST
    Biomed J; 2018 Dec; 41(6):348-355. PubMed ID: 30709576
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Addition of Basal Insulin to Oral Antidiabetic Agents in Patients with Inadequately Controlled Type 2 Diabetes Leads to Improved HbA1c Levels: Metabolic Control, Frequency of Hypoglycemia, and Insulin Titration Analysis as Results of a Prospective Observational Study (BALI Study).
    Brož J; Janíčková Ždárská D; Štěpánová R; Kvapil M
    Diabetes Ther; 2019 Apr; 10(2):663-672. PubMed ID: 30788806
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.